Merck Announces Personnel Changes

03-Feb-2015 - Germany

Merck announced that Andreas Stickler (43) has been appointed as new Head of Controlling of the Healthcare Business Sector. Roman Morten Werth (38) will succeed Andreas Stickler in his current position as Head of Mergers & Acquisitions (M&A). The changes will take effect on Feb. 1, 2015.

“We’re delighted that two key positions in our Finance Function will be filled with internal managers who bring the experience and the track record to ensure quality and continuity alike,” said Marcus Kuhnert, Chief Financial Officer and Member of the Executive Board of Merck.

In his new role, Andreas Stickler will be responsible for the largest of the three Business Sectors, which have been introduced on Jan. 1, 2015. In addition to the biopharmaceutical business Merck Serono, the Business Sector Healthcare also comprises the businesses Consumer Health, Biosimilars and Allergopharma. Andreas Stickler has headed the M&A department since 2008 and in that role led major transactions, including the takeover of Millipore (2010), AZ Electronic Materials (2014) and the planned acquisition of Sigma Aldrich (announced 2014). He joined Merck in 2002, following positions at Degussa, Aventis and Hoechst. Roman Werth joined the M&A department at Merck in 2008 and has played a key role in executing all major M&A projects. Prior to his career at Merck, he had worked several years at M&A departments of Siemens and Continental AG. In their new positions, Andreas Stickler and Roman Werth will both report directly to Marcus Kuhnert.

Since 2004 Merck has invested around €18 billion in acquisitions and generated around € 7 billion through divestments. The most recent transactions included the € 1.9 billion takeover of AZ Electronic Materials, a producer of high-tech electronic materials for displays. In September 2014, Merck announced an agreement to acquire Sigma-Aldrich for around € 13 billion to combine it with Merck Millipore and form one of the leading life science companies globally. Both transactions have marked major milestones in Merck’s “Fit for 2018” transformation and growth program aimed at building three strong platforms for sustainable, profitable growth.

https://www.bionity.com/en/news/151485/merck-announces-personnel-changes.html